Kara Fitzgerald, ND, received her doctor of naturopathic medicine degree from the National University of Natural Medicine in Portland, Oregon. She completed the first Counsel on Naturopathic Medicine-accredited post-doctorate position in nutritional biochemistry and laboratory science at Metametrix Clinical Laboratory under the direction of Richard Lord, PhD. Her residency was completed at Progressive Medical Center, a large, integrative medical practice in Atlanta, Georgia. Dr. Fitzgerald is the lead author and editor of Case Studies in Integrative and Functional Medicine and is a contributing author to Laboratory Evaluations for Integrative and Functional Medicine and the Institute for Functional Medicine (IFM)’s Textbook for Functional Medicine. With the Helfgott Research Institute, Dr. Fitzgerald is actively engaged in clinical research on the DNA methylome using a diet and lifestyle intervention developed in her practice. The first publication from the study focuses on reversal of biological aging and was published 04-12-2021 in the journal Aging. She has published a consumer book titled Younger You as well as a companion cookbook, Better Broths and Healing Tonics and has an application-based Younger You Program, based on the study. Dr. Fitzgerald is on the faculty at IFM, is an IFM Certified Practitioner and lectures globally on functional medicine. She runs a Functional Nutrition Residency program, and maintains a podcast series, New Frontiers in Functional Medicine and an active blog on her website, www.drkarafitzgerald.com. Her clinical practice is in Sandy Hook, Connecticut. Additional publications

Episode 60: Dutch™ Research And Validation In Peer-reviewed Journal Article

Episode 60: Dutch™ Research and Validation In Peer-Reviewed Journal Article

In today’s podcast, I chat with my friend and fellow laboratory geek Mark Newman, founder and president of Precision Analytical (creators of DUTCH), about his recent publication [Evaluating urinary estrogen and progesterone metabolites using dried filter paper samples and gas chromatography with tandem mass spectrometry (GC–MS/MS)], smartly published in an open access – and reputable – journal, BMC Chemistry, so it’s available to all, free of charge.

Cortisol & Sleep: The HPA Axis Activity Connection

Cortisol & Sleep: The HPA Axis Activity Connection

Cortisol and Sleep: The HPA Axis Activity Connection. Research in this area has been bursting forth recently, so I’m thrilled to feature a sponsored blog from Integrative Therapeutics written by one of my mentors, Tori Hudson, ND. You’re likely familiar with Dr. Hudson – her highly regarded Women’s Encyclopedia of Natural Medicine is a staple on many clinician’s shelves, including mine.

Clinician Position for SHC

Research and News March 2019

NSAIDs May Increase Risk for C. Difficile Infection
Protein & Fat Sources Matter on a Low-Carb Diet
Prebiotics Improve Bone Formation in Children with Celiac Disease
Update: Histamine Intolerance Symptoms
Sleep Disruption Creates Inflammation
Transforming 21st-Century Medicine – Clinical Ecology
Data Suggests Early-Life Antibiotic Exposure Tied to Celiac Risk
The Emergence of ‘Nutritional Psychiatry’

Episode 58: SPONSORED - Biocidin - Borrelia Research and Clinical Strategies using Botanical Antimicrobials

Episode 58: SPONSORED Biocidin – Borrelia Research and Clinical Strategies using Botanical Antimicrobials

Lyme disease (and co-infections) can be tough to treat. The Lyme spirochete, Borrelia burgdorferi, has adopted loads of devilishly clever cloaking devices – from thriving in biofilm to existing in pleomorphic forms – to ensure survival despite aggressive treatment. Enter botanical therapy. With or without concurrent antibiotics, botanical combinations are an essential component of the FxMed clinician’s toolkit.

Advances in Stool Testing: The GI-MAP™ GI-Microbial Assay Plus with Tony Hoffman

Episode 56: SPONSORED Advances in Stool Testing: The GI-MAP™ GI-Microbial Assay Plus with Tony Hoffman

I had loads of fun taking a tour through the wonderment of DSL GI MAP test today with Tony Hoffman, CEO of DSL (and longtime friend of mine!). DSL’s GI MAP stool test is, as CEO Tony Hoffman states, “a clinician diagnostic tool,” not a microbiome test. Yes, of course the GI MAP looks at the microbiome, but it’s not a broad sweep of the myriad bugs taking up residence.